AI assistant
Sending…
Cigna Group — Director's Dealing 2024
Mar 2, 2024
29918_dirs_2024-03-01_39277efc-37db-4860-9db5-d652103ea007.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Group (CI)
CIK: 0001739940
Period of Report: 2024-02-28
Reporting Person: Palmer Eric P (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-28 | Common Stock, $.01 Par Value | A | 5127.0000 | $0.0000 | Acquired | 50169.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-28 | Employee Stock Option (Right to Buy) | $336.4750 | A | 18677.0000 | Acquired | 2034-02-28 | Common Stock, $.01 Par Value (18677.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $.01 Par Value | 244.8499 | Indirect |
| Common Stock, $.01 Par Value | 41.1149 | Indirect |
| Common Stock, $.01 Par Value | 1437.0000 | Indirect |
Footnotes
F1: These restricted shares vest in three equal annual installments beginning March 1, 2025.
F2: Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
F3: This option vests in three equal annual installments beginning March 1, 2025.
More from Cigna Group
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4